StabiLux receives funding for high-brightness fluorophore development

The funding will support commercialization of high-brightness fluorophores for use in multicolor flow cytometry.

Nov. 8, 2017

StabiLux Biosciences, a company founded by Michigan Technological University (Houghton, MI) physics professor Yoke Khin Yap, has been awarded more than $650,000 to support commercialization of high-brightness fluorophores for use in multicolor flow cytometry for medical diagnostics and analysis.

The funding comes from America's Seed Fund, powered by the National Science Foundation (NSF) Small Business Innovation Research/Small Business Technology Transfer (SBIR/STTR) program and the Invest Michigan's University Commercialization Fund (UCF), which provides funding to early-stage companies for the commercialization of technologies originating from Michigan's 15 public universities.

The company was awarded a $600,000 grant from NSF-STTR phase II to commercialize the technology by conducting research and development for biomedical applications. It will commercialize its high-brightness fluorophores under the registered trademark of NovoLux.

For more information, please visit stabiluxbiosciences.com.